论文部分内容阅读
目的分析评价《中国新药与临床杂志》的载文质量和学术水平。方法文献计量法和引文分析法。数据来源于维普引文数据库和CBMdisc,数据全部采用自编的计算机引文分析软件进行处理,分析指标包括期刊被引量,核心期刊引用量,被引文献年代分布及被引时差以及源文献来源期刊分布等。结果共有1338篇文献被国内的期刊引用2158次,1999～2000年年平均被引777.5±19.09篇次。被引时差平均为74.02月,引用高峰在1995～1998年4年间,共被引用1461次,占全部被引篇次的67.70%,高峰期年平均被引率为57.23%。涉及期刊298种,引用超过10次的有45种,近30%为国内医药学核心期刊,超过40%的被引频次为核心期刊所为。自被引率为25.67%,自引率为13.06%。2000年期刊影响因子为0.551。结论该刊载文质量高,被引率高,自引率与80年代美国较著名的学术专业期刊相近;作者的研究具有延续性和连贯性,报道具有稳定和连续的优点;有一定数量的较为固定的关联期刊;是药学研究的重要期刊和核心期刊;多引文献较少,尚未产生具有深远影响的文献。
Objective To analyze and evaluate the quality and academic level of the articles published in China Journal of New Drugs and Clinical Medicine. Methods Bibliometrics and Citation Analysis. The data come from the Vip Citation Database and the CBMdisc. The data are all processed by the self-compiled computer citation analysis software. The analysis indexes include the journals cited, the quotations of core journals, the distribution and the cited time difference of cited citation and the distribution of journals of source literature Wait. Results A total of 1338 articles were cited by domestic journals for 2158 times, and the average annual quotation was 777.5 ± 19.09 articles from 1999 to 2000. The average time quoted was 74.2 months. The quoted peak was cited 1461 times in the four years from 1995 to 1998, accounting for 67.70% of the total quoted articles. The annual average cited rate was 57.23%. 298 journals were involved, 45 were cited more than 10 times, and nearly 30% were core journals of domestic medicine. More than 40% of them were cited as core journals. Since the rate was 25.67%, self-cited rate of 13.06%. The impact factor of 2000 journals is 0.551. Conclusion The papers published in this journal are of high quality, high citation rate and self-citation rates similar to the more famous academic journals of the United States in the 1980s. The author’s research is both continuous and coherent. The reports have the advantages of stability and continuity. There are a number of relatively fixed Related journals; is an important periodical and core journals in pharmaceutical research; there are fewer articles with more references and no far-reaching literature has been produced yet.